University of Oxford at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of Oxford takes part in 4 sessions at ESMO 2026 in Madrid. Its program covers early drug development, new treatment targets and ways to make cancer care more environmentally sustainable. It also presents research on how mitochondrial genetics shape T cell energy use and immune responses after immune checkpoint blockade.

OrganizationESMO 2026 Attendance
University of Oxford
Oxford, United Kingdom
ox.ac.uk
University & institute
Collegiate research university in Oxford, United Kingdom, with a medical school and cancer research.
Talk
Sat Oct 24
10:30–10:45
Chair
Sun Oct 25
08:30–10:00
Rapid oral: Developmental therapeutic
with START Center for Cancer Care, Gustave Roussy
Abstract
Sun Oct 25
09:32–09:44
Invited Discussant 1008RO, 1009RO and LBA34
Rapid oral: Developmental therapeutic
Chair
Mon Oct 26
08:30–10:00
New targets and strategies
with MD Anderson Cancer Center
Abstract
Mon Oct 26
10:42–10:47

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Oxford

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction